ZA963775B - 15-Deoxyspergualin analogs, their method of preparation and their use in therapeutics - Google Patents

15-Deoxyspergualin analogs, their method of preparation and their use in therapeutics

Info

Publication number
ZA963775B
ZA963775B ZA963775A ZA963775A ZA963775B ZA 963775 B ZA963775 B ZA 963775B ZA 963775 A ZA963775 A ZA 963775A ZA 963775 A ZA963775 A ZA 963775A ZA 963775 B ZA963775 B ZA 963775B
Authority
ZA
South Africa
Prior art keywords
therapeutics
preparation
nhr1
deoxyspergualin
analogs
Prior art date
Application number
ZA963775A
Other languages
English (en)
Inventor
Luc Lebreton
Patrice Renaut
Christine Dumas
Original Assignee
Fournier Ind & Sante
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fournier Ind & Sante filed Critical Fournier Ind & Sante
Publication of ZA963775B publication Critical patent/ZA963775B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/02Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C215/04Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated
    • C07C215/06Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic
    • C07C215/14Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic the nitrogen atom of the amino group being further bound to hydrocarbon groups substituted by amino groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06Antimalarials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06Esters of carbamic acids
    • C07C271/08Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/20Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by nitrogen atoms not being part of nitro or nitroso groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/04Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
    • C07C279/12Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by nitrogen atoms not being part of nitro or nitroso groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/04Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
    • C07C279/14Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by carboxyl groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/20Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylguanidines
    • C07C279/24Y being a hetero atom
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Transplantation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
ZA963775A 1995-05-17 1996-05-13 15-Deoxyspergualin analogs, their method of preparation and their use in therapeutics ZA963775B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9505862A FR2734263B1 (fr) 1995-05-17 1995-05-17 Analogues de la 15-deoxyspergualine, leur procede de preparation et leur utilisation en therapeutique

Publications (1)

Publication Number Publication Date
ZA963775B true ZA963775B (en) 1996-11-25

Family

ID=9479086

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA963775A ZA963775B (en) 1995-05-17 1996-05-13 15-Deoxyspergualin analogs, their method of preparation and their use in therapeutics

Country Status (22)

Country Link
US (1) US5733928A (de)
EP (1) EP0743300B1 (de)
JP (1) JP2860778B2 (de)
KR (1) KR960041153A (de)
CN (1) CN1063744C (de)
AT (1) ATE182882T1 (de)
AU (1) AU694342B2 (de)
CA (1) CA2176670C (de)
CZ (1) CZ292373B6 (de)
DE (1) DE69603541T2 (de)
DK (1) DK0743300T3 (de)
ES (1) ES2137634T3 (de)
FR (1) FR2734263B1 (de)
GR (1) GR3031684T3 (de)
HU (1) HUP9601323A3 (de)
NO (1) NO306397B1 (de)
NZ (1) NZ286582A (de)
RU (1) RU2130015C1 (de)
SK (1) SK283372B6 (de)
TW (1) TW354782B (de)
UA (1) UA42798C2 (de)
ZA (1) ZA963775B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5843995A (en) * 1997-07-07 1998-12-01 University Of Medicine And Dentistry Of New Jersey Inhibition of HIV-1 replication using oligocarbamate derivatives
DE19737463A1 (de) * 1997-08-28 1999-03-04 Hoechst Marion Roussel De Gmbh Verwendung von Inhibitoren des Natrium-Wasserstoff-Austauschers zur Herstellung eines Arzneimittels zur Behandlung von Erkrankungen, die durch Protozoen verursacht werden
DE19923961A1 (de) * 1999-05-25 2000-11-30 Euro Nippon Kayaku Gmbh Verwendung von 15-Deoxyspergualin zur Behandlung von hyperreaktiven entzündlichen Erkrankungen und Autoimmunerkrankungen

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5942356A (ja) * 1982-09-02 1984-03-08 Microbial Chem Res Found スパガリン関連化合物およびその製造法
JPS61129119A (ja) * 1984-11-13 1986-06-17 Microbial Chem Res Found 新規免疫抑制剤
US4990536A (en) * 1989-04-03 1991-02-05 Nippon Kayaku Kabushiki Kaisha Immunopotentiator and spergualin-related compound therefor
FR2698628B1 (fr) * 1992-12-02 1995-02-17 Fournier Ind & Sante Analogues de 15-déoxyspergualine, leur procédé de préparation et leur utilisation en thérapeutique.
FR2716452B1 (fr) * 1994-02-24 1996-05-10 Fournier Ind & Sante Analogues de la 15-déoxyspergualine, leur procédé de préparation et leur utilisation en thérapeutique.

Also Published As

Publication number Publication date
UA42798C2 (uk) 2001-11-15
NO961891D0 (no) 1996-05-10
FR2734263B1 (fr) 1997-06-20
DE69603541D1 (de) 1999-09-09
GR3031684T3 (en) 2000-02-29
EP0743300B1 (de) 1999-08-04
HUP9601323A2 (en) 1997-05-28
HUP9601323A3 (en) 1998-04-28
FR2734263A1 (fr) 1996-11-22
SK63696A3 (en) 1996-12-04
DE69603541T2 (de) 2000-04-06
US5733928A (en) 1998-03-31
NZ286582A (en) 1998-07-28
AU5208196A (en) 1996-11-28
CA2176670A1 (en) 1996-11-18
CN1143075A (zh) 1997-02-19
KR960041153A (ko) 1996-12-19
TW354782B (en) 1999-03-21
SK283372B6 (sk) 2003-06-03
CZ142396A3 (en) 1997-02-12
NO961891L (no) 1996-11-18
EP0743300A1 (de) 1996-11-20
CA2176670C (en) 2002-03-26
NO306397B1 (no) 1999-11-01
JPH0977733A (ja) 1997-03-25
RU2130015C1 (ru) 1999-05-10
AU694342B2 (en) 1998-07-16
HU9601323D0 (en) 1996-07-29
CZ292373B6 (cs) 2003-09-17
ES2137634T3 (es) 1999-12-16
ATE182882T1 (de) 1999-08-15
JP2860778B2 (ja) 1999-02-24
CN1063744C (zh) 2001-03-28
DK0743300T3 (da) 2000-01-24

Similar Documents

Publication Publication Date Title
CA2118812A1 (en) 5-ht4 receptor antagonists
TW330202B (en) Substituted heterocyclic carboxamide esters, their preparation and their use as pharmaceuticals
GR3034426T3 (en) Urea and amide derivatives having ACAT inhibitory activity, their preparation and their therapeutic and prophylactic use
SE9301911D0 (sv) New peptide derivatives
EP0577847A4 (de) Morphinan-derivate und medizinische verwendung.
ES2091212T3 (es) Compuestos de xantina.
ES2001698A6 (es) Un procedimiento para la preparacion de derivados de sulfonilurea.
ES2053439T3 (es) Un procedimiento para la preparacion de un compuesto que tiene propiedades farmacologicas utiles.
IL106387A (en) Indole derivatives, their preparation and pharmaceutical compositions containing them
GR3027694T3 (en) Naphthyloxyacetic acid derivatives as PGE2 agonists and antagonists.
EP0934932A4 (de) Chinolinderivate und psychotropes mittel
MY107814A (en) Novel antimicrobial quinolony lactams.
ZA963775B (en) 15-Deoxyspergualin analogs, their method of preparation and their use in therapeutics
EP0205334A3 (de) Benzazepinderivate
TR199902043T2 (xx) Sabit, higroskopik olmayan (-) karnitin tuzlar�n� haz�rlama y�ntemi.
ES8401930A1 (es) Un procedimiento para preparar derivados de amida del acido nitrobenzoico.
HU9201575D0 (en) Pyrimidone derivatives and their analogues
DK624989D0 (da) Hidtil ukendte forbindelser
GR3002225T3 (en) 1,5-benzothiazepine derivatives, their preparation and their therapeutical use
DK526087D0 (da) Antikonvulsive aminosyrederivater
AU1028895A (en) 15-deoxyspergualin analogs, their method of preparation and their use in therapeutics
ATE41145T1 (de) Antikonvulsiermittel.
JPS6438091A (en) Condensed heterocyclic sulfonylurea
FI904449A0 (fi) N-azasicyklo/3.3.0/oktanamider av aromatiska syror.
CA2277151A1 (en) Synthesis of acyclic nucleoside derivatives